BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8487047)

  • 1. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children.
    Gamis AS; Haake R; McGlave P; Ramsay NK
    J Clin Oncol; 1993 May; 11(5):834-8. PubMed ID: 8487047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
    Weisdorf DJ; Anasetti C; Antin JH; Kernan NA; Kollman C; Snyder D; Petersdorf E; Nelson G; McGlave P
    Blood; 2002 Mar; 99(6):1971-7. PubMed ID: 11877268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia.
    Yagasaki H; Takahashi Y; Hama A; Kudo K; Nishio N; Muramatsu H; Tanaka M; Yoshida N; Matsumoto K; Watanabe N; Kato K; Horibe K; Kojima S
    Bone Marrow Transplant; 2010 Oct; 45(10):1508-13. PubMed ID: 20118992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia.
    Reiter E; Greinix HT; Keil F; Brugger S; Rabitsch W; Schulenburg A; Mannhalter C; Schwarzinger I; Worel N; Volc-Platzer B; Fischer G; Dieckmann K; Hinterberger W; Schneider B; Haas OA; Geissler K; Kalhs P
    Ann Hematol; 1999 Nov; 78(11):507-13. PubMed ID: 10602894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
    Arora M; Weisdorf DJ; Spellman SR; Haagenson MD; Klein JP; Hurley CK; Selby GB; Antin JH; Kernan NA; Kollman C; Nademanee A; McGlave P; Horowitz MM; Petersdorf EW
    J Clin Oncol; 2009 Apr; 27(10):1644-52. PubMed ID: 19224849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts.
    Davies SM; Ramsay NK; Haake RJ; Kersey JH; Weisdorf DJ; McGlave PB; Blazar BR
    Bone Marrow Transplant; 1994 Jan; 13(1):51-7. PubMed ID: 8019453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission.
    Saarinen-Pihkala UM; Gustafsson G; Ringdén O; Heilmann C; Glomstein A; Lönnerholm G; Abrahamsson J; Bekassy AN; Schroeder H; Mellander L;
    J Clin Oncol; 2001 Jul; 19(14):3406-14. PubMed ID: 11454889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.
    McGlave PB; Shu XO; Wen W; Anasetti C; Nademanee A; Champlin R; Antin JH; Kernan NA; King R; Weisdorf DJ
    Blood; 2000 Apr; 95(7):2219-25. PubMed ID: 10733488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study of 19 cases of unrelated heterogenic bone marrow transplantation].
    Xu L; Huang X; Ren H; Zhang Y; Guo N; Lu D
    Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):256-8. PubMed ID: 12133439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
    Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J
    Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow transplantation from unrelated donors in chronic myeloid leukemia: the results in 15 patients].
    Sierra J; Carreras E; Rovira M; Batlle M; Urbano-Ispizua A; Marín P; Besson I; Merino A; Algara M; Cervantes F
    Med Clin (Barc); 1995 May; 104(18):689-94. PubMed ID: 7769878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
    Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
    Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.